ArticleScientific reports2025
Artificial intelligence based automatic classification, annotation, and measurement of the fetal heart using HeartAssist.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- A multi-task deep learning and radiomics framework for fetal anatomical structure detection and classification in ultrasound imaging.Scientific reports · 2026Article
- AI-enabled obstetric point-of-care ultrasound as an emerging technology in low- and middle-income countries: provider and health system perspectives.BMC pregnancy and childbirth · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the feasibility of HeartAssist, a novel automated tool designed for classification of fetal cardiac views, annotation of cardiac structures, and measurement of cardiac parameters. Unlike previous AI tools that primarily focused on classification, HeartAssist integrates classification, annotation and measurement capabilities, enabling a more comprehensive fetal cardiac assessment.Cardiac images from fetuses (gestational ages 20-40 weeks) were collected at Asan Medical Center between January 2016 and October 2018. HeartAssist was developed using convolutional neural networks to classify 10 cardiac views, annotate 26 structures, and measure 43 parameters. One expert performed manual classifications, annotations, and measurements, which were then compared to HeartAssist outputs to assess feasibility. A total of 65,324 images from 2,985 fetuses were analyzed. HeartAssist achieved 99.4% classification accuracy, with recall, precision, and F1-score of 0.93, 0.95, and 0.94, respectively. Annotation accuracy was 98.4%, while the automatic measurement success rate was 97.6%, with an error rate of 7.62% and caliper similarity of 0.613. HeartAssist is a reliable tool for fetal cardiac screening, demonstrating high accuracy in classifying cardiac views and annotating structures, with comparable outcomes in measuring cardiac parameters. This tool could enhance prenatal detection of congenital heart disease and improve perinatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.